Suite 410-103 East Holly Street
Bellingham, WA 98225
Telephone: (360) 306 1133
Fax: (360) 230-7304

CNNMoney.com	Nasdaq
Caleco Pharma Corp OTC BB: CAEH.OB	Caleco Pharma Corp. CAEH.F FRANKFURT LISTING T3R.FSE
New: Canadian Business	investing businessweek
Marketwatch	The Green Baron

A New Audio Interview with Jim Sandino of Caleco Pharma Corp.
Market Demand for Caleco's Liver Health Formulation (Marketwire)

CALECO PHARMA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur (EDGAR Online)

Laboratory Facilities and Service Agreement Signed by Caleco Pharma Corp. (Marketwire)

CALECO PHARMA CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob (EDGAR Online)

Caleco Pharma Provides Corporate Update (Marketwire)

Caleco Pharma Corp. Announces Entry Into Share Purchase Agreement With Natac Biotech S.L. (Marketwire)

CALECO PHARMA CORP. Files SEC form 10-K, Annual Report (EDGAR Online)

Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant (Marketwire)

CALECO PHARMA CORP. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial S (EDGAR Online)

Caleco Pharma Corp. Announces Corporate Alliance With Rearden Health Partners (Marketwire)